H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.2% of adults in Sacramento have diagnosed diabetes — 0.8 points below the U.S. 12% figure. Census population 524,943. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Sacramento clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Sacramento storefront.
Wharton's Jelly Allograft Products in Sacramento, CA for clinics & physicians. Wharton's jelly allografts… Compliance support & pricing — contact Hawk Medical.
Sacramento is a city of 500k–1M (524,943 Census). CDC PLACES (2023, crude) estimates 11.2% of adults in Sacramento have diagnosed diabetes — 0.8 points below the U.S. 12% figure. Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Wharton's Jelly Allograft Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 11.2% of adults in Sacramento have diagnosed diabetes — 0.8 points below the U.S. 12% figure. Adult obesity in Sacramento is 30% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JE / Noridian Healthcare Solutions, sibling states HI, NV. California Department of Public Health is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Sacramento warehouse or a five-star local review. What you get is whartons jelly allograft from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JE, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 11.2% of adults — 0.8 points below the U.S. 12% figure. Obesity is 30%; arthritis is 21.2%. That is place-level BRFSS modeling, not a clinic census and not a Sacramento trial.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JE reviewers and surveyors expect — not a brochure.
Ask for the IFU, the lot-traceability packet, and the Noridian Healthcare Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Sacramento fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Sacramento, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Sacramento is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Sacramento — 0.8 points below the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Sacramento. Useful for joint-program math; still needs a diagnosis and privileging.
No Sacramento storefront. Joe Bradley is an active practice owner. whartons jelly allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.